Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 US FDA approves new class of HIV therapeutics.

× No keyword cloud information.

16 in total

1. The appealing story of HIV entry inhibitors : from discovery of biological mechanisms to drug development.

Authors: Antonella Castagna; Priscilla Biswas; Alberto Beretta; Adriano Lazzarin
Journal: Drugs Date: 2005 Impact factor: 9.546

Review 2. Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.

Authors: Andrew W Woodham; Joseph G Skeate; Adriana M Sanna; Julia R Taylor; Diane M Da Silva; Paula M Cannon; W Martin Kast
Journal: AIDS Patient Care STDS Date: 2016-07 Impact factor: 5.078

3. Increasing hydrophobicity of residues in an anti-HIV-1 Env peptide synergistically improves potency.

Authors: Michael Y K Leung; Fredric S Cohen
Journal: Biophys J Date: 2011-04-20 Impact factor: 4.033

4. Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure.

Authors: Marcelo T Augusto; Axel Hollmann; Miguel A R B Castanho; Matteo Porotto; Antonello Pessi; Nuno C Santos
Journal: J Antimicrob Chemother Date: 2014-01-23 Impact factor: 5.790

5. Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: Part I. fusion [corrected] inhibition.

Authors: Sylvia Lee-Huang; Philip Lin Huang; Dawei Zhang; Jae Wook Lee; Ju Bao; Yongtao Sun; Young-Tae Chang; John Zhang; Paul Lee Huang
Journal: Biochem Biophys Res Commun Date: 2007-01-24 Impact factor: 3.575

6. Enzymatic glycosylation of triazole-linked GlcNAc/Glc-peptides: synthesis, stability and anti-HIV activity of triazole-linked HIV-1 gp41 glycopeptide C34 analogues.

Authors: Wei Huang; Stan Groothuys; Alonso Heredia; Brian H M Kuijpers; Floris P J T Rutjes; Floris L van Delft; Lai-Xi Wang
Journal: Chembiochem Date: 2009-05-04 Impact factor: 3.164

7. Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc.

Authors: Olga Latinovic; Janaki Kuruppu; Charles Davis; Nhut Le; Alonso Heredia
Journal: Clin Med Ther Date: 2009

8. The membrane proximal external region of the HIV-1 envelope glycoprotein gp41 contributes to the stabilization of the six-helix bundle formed with a matching N' peptide.

Authors: Eran Noah; Zohar Biron; Fred Naider; Boris Arshava; Jacob Anglister
Journal: Biochemistry Date: 2008-06-10 Impact factor: 3.162

Review 9. Recent progress in antiretrovirals--lessons from resistance.

Authors: Catherine S Adamson; Eric O Freed
Journal: Drug Discov Today Date: 2008-04-18 Impact factor: 7.851

Review 10. HIV entry inhibitors and their potential in HIV therapy.

Authors: Keduo Qian; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal: Med Res Rev Date: 2009-03 Impact factor: 12.944